Erlotinib With Concurrent Brain Radiotherapy and Secondary Brain Radiotherapy After Recurrence With Erlotinib in NSCLC Non-increased-intracranial-pressure Symptomatic Brain Metastases (TRACTS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01763385
Recruitment Status : Unknown
Verified December 2014 by Yang Huan Jun, Fudan University.
Recruitment status was:  Recruiting
First Posted : January 8, 2013
Last Update Posted : December 23, 2014
Fudan University
Changhai Hospital
Shanghai Pulmonary Hospital, Shanghai, China
Longhua Hospital
RenJi Hospital
Shanghai Armed Police Hospital
Shanghai Chest Hospital
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai Changzheng Hospital
Information provided by (Responsible Party):
Yang Huan Jun, Fudan University

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : May 2016
  Estimated Study Completion Date : May 2016